Open standards for pre-treatment assessment in aesthetic medicine.
Aesthetic Health Standards publishes the Aesthetic Risk Score specification: its scale, bands, assessment domains, and the guidelines behind every factor.
Status: the Aesthetic Risk Score specification v2.1 is a public draft. The Clinical Advisory Board is being constituted and is not yet seated; until its members are named and published, the specification should be read as a rubric published for inspection, not yet an independently governed standard.
The Aesthetic Risk Score
A structured pre-screening rubric for elective cosmetic procedures. It organizes what a practitioner already weighs, including history, medications, skin type, and timing, into one documented assessment. It does not diagnose, authorize, or deny treatment, and it never substitutes for the Good Faith Examination.
The specification defines the score for implementers and reviewers: what conforming software must disclose to the practitioner, what it must never transmit to a client, and how a score remains reproducible when it is challenged.
- Scale300 to 850, lower is lower risk
- Bands4, at fixed published thresholds
- Assessment domains8, with published weightings
- Guideline register13 entries, 9 authorities
- Current versionv2.1, public draft
300 to 449
450 to 579
580 to 699
700 to 850
- 25%Examination state, history, timing
- 21%Systemic and metabolic conditions
- 14%Bleeding, healing, genetics
- 11%Medication and washout
- 11%Psychological screening
- 11%Allergy and hypersensitivity
- 4%Constitutional
- 3%Skin typing and photo-exposure
What is published, and what is not
The specification separates two transparency duties. The practitioner reviewing an individual score receives its complete clinical basis. The public document discloses the structure of the rubric, and withholds its calibration.
The structure
- The scale, its polarity, and the band thresholds
- Eight assessment domains and their relative weightings
- Clinical cut-points, taken from the published guidelines
- The guideline register, with full citations
- Decay principles and regulatory washout periods
- Conformance requirements, self-assessable in full
The calibration
- Individual factor point values and the baseline anchor
- Decay half-lives and horizons not fixed by regulators
- Data-quality allocations and confidence-interval widths
Disclosed under binding confidentiality to the advisory board, validation investigators, regulators, carriers in diligence, and any proceeding in which a score is materially at issue. Specification, section 2.3.
Governance and validation
A standard is credible for what it admits as much as for what it claims. Both of the following status entries will change, and this page will change with them.
Clinical Advisory Board
Being constitutedAmendments to the specification are made by the ARS Clinical Advisory Board. Planned composition: dermatologists, plastic surgeons, core aesthetic physicians, an advanced-practice clinician, an ethicist, and a patient advocate, with published authority over the rubric and full access to it. Members and terms of reference will be published here when the board is seated.
Validation program
Planned, not startedThe Aesthetic Risk Score has not been prospectively validated against clinical outcomes, and no implementation may claim otherwise. The planned program is a prospective, multi-site study of 3,000 to 5,000 patients across 8 to 12 sites over 12 months, with a composite 30-day adverse-event endpoint. The protocol will be published before enrollment opens.
Provenance
DisclosedAesthetic Health Standards was established by the team behind PRIX360, the specification's first implementer. The specification is published for open implementation, and the governance above exists to move authority over the rubric from the vendor to an independent board. Read the specification with that relationship in view.
Contact
Questions about the specification, the validation program, controlled disclosure, or use of the marks: standards@aesthetichealthstandards.org